JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

210 hedge funds and large institutions have $3.62B invested in Juno Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 64 increasing their positions, 55 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

16% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 55

11% less call options, than puts

Call options by funds: $63.4M | Put options by funds: $71.6M

Holders
210
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$63.4M
Puts
$71.6M
Net Calls
Net Calls Change

Top Buyers

1 +$256M
2 +$59.9M
3 +$55.2M
4
O
OrbiMed
New York
+$50.5M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$41.1M

Top Sellers

1 -$360M
2 -$66.3M
3 -$35M
4
State Street
State Street
Massachusetts
-$25.4M
5
Millennium Management
Millennium Management
New York
-$18.6M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$487M
2
$419M
3
$301M
4
$256M
5
$203M
6
$120M
7
$102M
8
$92.2M
9
$91.6M
10
$89.2M
11
$87.9M
12
$83.6M
13
$78.5M
14
$65.1M
15
$58.9M
16
$58.1M
17
$50.7M
18
$48.2M
19
$42.9M
20
$41.3M
21
$41.1M
22
$40.3M
23
$37.4M
24
$37.4M
25
$34M